Delivery Order SPE2DR25D2100-SPE2DR26FA0RM
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on November 14, 2025, for the supply of Mesalamine DR 400 mg capsules (180 count) valued at $9,632.65. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 17, 2025. The order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,993.43 to AmerisourceBergen Drug Corp for Mesalamine DR 400 mg capsules (180 count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. The product will be performed and delivered from AmerisourceBergen's corporate office located in...
- The Defense Logistics Agency awarded a $3,190.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Mesalamine DR 400 mg capsules (180 count). This is a non-set-aside contract with an ultimate completion date of December 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,619.57 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count units). This contract type is a firm fixed-price delivery order with no set-aside designation, executed on June 17, 2025, with an ultimate completion date of June 18, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $7,361.02 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mesalamine 400 mg capsules (180-count units). This non-set-aside contract features firm fixed pricing and is scheduled for completion by July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under AmerisourceBergen's broader federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,991.90 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180 count) on November 14, 2025, with completion expected by November 17, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Mesalamine is a gastrointestinal anti-inflammatory medication commonly...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $3,543.41 by the Defense Logistics Agency to supply Mesalamine DR 1.2 GM tablets (120-count units). The contract, awarded on November 6, 2025, with completion scheduled for November 7, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation, indicating competitive award. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $5,911.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 180 capsules of Mesalamine 400 mg, with an ultimate completion date of December 15, 2025. This non-set-aside contract represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded a $8,989.14 delivery order to AmerisourceBergen Drug Corp for 180 capsules of Mesalamine 400 mg on December 12, 2025, with an ultimate completion date of December 15, 2025. This is a firm fixed-price contract with no set-aside designation, issued as a competitive award. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations center. This delivery order...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Mesalamine ER 0.375 gram capsules (120-count). This is a firm fixed price delivery order with a ceiling value of $7,754.63 and an ultimate completion date of September 9, 2025. The award represents a non-competitive procurement and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DR25D2100Indefinite Delivery Contract
- SPE2DR25D2100-SPE2DR26FA0RMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,813.12 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count units). This competitively awarded, firm fixed price contract was executed on December 16, 2025, with an ultimate completion date of December 17, 2025. The contract is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering a comprehensive range of pharmaceutical products, including brand-name and generic medications, across multiple therapeutic domains. As a child contract under the DLA Troop Support Medical IDC, this delivery order exemplifies the company's capability to fulfill federal medical supply requirements through competitive procurement processes with firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 12/15/25 |